Recording stroke onset time and minimizing delay between onset and presentation to ED are critical for patients with cerebral infarction because effective treatment with recombinant tissue-type plasminogen activator has a post-onset treatment window of 4.5 hours [16]. This evidence concerns the gene PLAT and stroke disorder.